RNU1-117P

Across TCGA pan-cancer cohorts, RNU1-117P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNU1-117P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RNU1-117P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU1-117P is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

KIRC and STAD are the cancer types where RNU1-117P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU1-117P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	−0.033	.006	6	view →
STAD	All	III,IV	+0.202	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RNU1-117P–KIRC

Open the KIRC breakdown →